CELLINK is the leading bio-convergence company and a global provider of technologies, products and services to create, understand and master biology. With a focus on the areas of bioprinting, biosciences and industrial solutions, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. CELLINK’s products are trusted by more than 1,800 laboratories, including ones at all the top 20 pharmaceutical companies, are being used in more than 60 countries, and have been cited in more than 700 publications. CELLINK is creating the future of medicine.

For more than 40 years ratiolab® is developing in close co-operation with its customers professional solutions for the laboratory routine, the research, and the development: disposables for sciences. Today the product range covers four branches: cryo-products, liquid-handling, life-science, and lab-ware. Ratiolab® co-operates with laboratory dealers in more than 30 countries.

The MVE range of cryogenic freezers and aluminium dewars have been engineered for ultimate reliability and maximizing hold times at the ultra-low temperatures vital to the preservation of critical human and animal tissues and vaccines. The application areas include bio-pharma including cell & gene therapies storage of cord blood, bone marrow, stem cell, heart valves and other highly sensitive human tissue medical research facilities and universities vaccines, government institutions including CDC and NIH IVF centers hospitals and clinics animal husbandry, breeders and livestock.

MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. MGI focuses on R&D, production and sales of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, mass spectrometry, medical imaging, and laboratory automation..

Established in 1984, Haier Group is a world-leading provider of solutions for a beautiful life. In the process of innovation and entrepreneurship, Haier always upholds the principle of “prioritizing people’s value”. Haier has established 10+ N R&D centres, 25 industrial parks, 122 manufacturing plants and 108 marketing centres all over the world. Haier also boasts a large retailer network that covers over 160 countries in the world. It owns a number of smart-appliance brands, including biosafety cabinets, refrigerant freezing unit and cold storage units.

Allentown is a leading global provider in Life Science solutions. In over 50 years of operation, high-quality equipment and advanced vivarium systems continue to define and exceed industry standards. Allentown is proud to have played their part in heroic research that continues to save lives around the world. They have gained the highest trust of the biomedical research community by providing critical services with integrity and care.

The need for accurate and reliable HLA typing results using contemporary technology for your research is something Jeenomics is familiar with. Most importantly, you need someone who understands your research and contributes to your quest. Jeenomics has the team you are looking for in an NGS HLA laboratory accredited nationally and internationally with several publications in peer reviewed journals.

CARPL – The Analytics Platform – is an end-to-end testing and deployment platform to deploy Artificial Intelligence (A.I.) and advanced analytics tools in hospitals and out-patient care-centres. By becoming part of the CARING network you get access to the world’s best medical A.I. products from companies across the globe. CARPL can read MRI scans, CT scans and X-Ray scans automatically reducing turn-around-times, improving quality and adding efficiency to your healthcare system..

Oasis Diagnostics® Corporation was founded in 2002 to address a growing need for non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics [DNA, RNA and proteins] in the Life Sciences area. The Company is dedicated to meeting the need for more effective screening tools, which may be applied to the early detection of diseases and medical disorders, utilizing non-invasive test specimens, particularly oral fluids (saliva).
The Company’s range of collection and [future] diagnostic tools are covered by a portfolio of issued US, EU and International patents

SkinDNA®™ is a world leader in research and scientific advancement in predictive skin ageing and clinical product recommendation. Invented in 2008, SkinDNA®™ is now distributed in more than 20 countries around the world.

SkinDNA is dedicated to the research and development of new therapies for skin improvement tailored to an individual’s genetic structure. SkinDNA’s technology and training modules have been internationally adopted and implemented through various products around the globe.